Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jimmi Søndergaard, Mats Holmberg, Annette Ross Jakobsen, Mads Agerbæk, Ludvig Paul Muren & Morten Høyer. (2014) A comparison of morbidity following conformal versus intensity-modulated radiotherapy for urinary bladder cancer. Acta Oncologica 53:10, pages 1321-1328.
Read now
Read now
Mohamed S Zaghloul & Amr G Mousa. (2010) Trimodality treatment for bladder cancer: does modern radiotherapy improve the end results?. Expert Review of Anticancer Therapy 10:12, pages 1933-1944.
Read now
Read now
Articles from other publishers (15)
Rodrigo Barros, Luciano A. Favorito, Bruno Nahar, Ricardo Almeida Jr & Ranjith Ramasamy. (2023) Changes in male sexuality after urologic cancer: a narrative review. International braz j urol 49:2, pages 175-183.
Crossref
Crossref
Gokhan Ozyigit, Pervin Hurmuz, Sezin Yuce Sari, Cem Onal, Fatih Biltekin, Melis Gultekin, Gozde Yazici, Ozan Cem Guler & Fadil Akyol. 2019. Radiation Oncology. Radiation Oncology
269
307
.
Ozan Cem Guler & Cem Onal. 2017. Principles and Practice of Urooncology. Principles and Practice of Urooncology
85
101
.
Anne Vestergaard, Jesper Folsted Kallehauge, Jørgen Breede Baltzer Petersen, Morten Høyer, Jimmi Søndergaard & Ludvig Paul Muren. (2014) An adaptive radiotherapy planning strategy for bladder cancer using deformation vector fields. Radiotherapy and Oncology 112:3, pages 371-375.
Crossref
Crossref
Anne Vestergaard, Ludvig Paul Muren, Jimmi Søndergaard, Ulrik Vindelev Elstrøm, Morten Høyer & Jørgen B. Petersen. (2013) Adaptive plan selection vs. re-optimisation in radiotherapy for bladder cancer: A dose accumulation comparison. Radiotherapy and Oncology 109:3, pages 457-462.
Crossref
Crossref
S. Singer, C. Ziegler, T. Schwalenberg, A. Hinz, H. Götze & T. Schulte. (2012) Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer. Supportive Care in Cancer 21:5, pages 1383-1393.
Crossref
Crossref
M.R. Button & J.N. Staffurth. (2010) Clinical Application of Image-guided Radiotherapy in Bladder and Prostate Cancer. Clinical Oncology 22:8, pages 698-706.
Crossref
Crossref
Xiangfei Chai, Marcel van Herk, Jeroen B. van de Kamer, Peter Remeijer, Axel Bex, Anja Betgen, Theo M. De Reijke, Maarten C.C.M. Hulshof, Floris J. Pos & Arjan Bel. (2010) Behavior of Lipiodol Markers During Image Guided Radiotherapy of Bladder Cancer. International Journal of Radiation Oncology*Biology*Physics 77:1, pages 309-314.
Crossref
Crossref
Peter Hoskin, Ana Rojas & Michele Saunders. (2009) Accelerated Radiotherapy, Carbogen, and Nicotinamide (ARCON) in the Treatment of Advanced Bladder Cancer: Mature Results of a Phase II Nonrandomized Study. International Journal of Radiation Oncology*Biology*Physics 73:5, pages 1425-1431.
Crossref
Crossref
Bruce Turner. (2008) Bladder cancer: an update. International Journal of Urological Nursing 2:3, pages 91-102.
Crossref
Crossref
Ludvig Paul Muren, Anthony Thomas Redpath, Hannah Lord & Duncan McLaren. (2007) Image-guided radiotherapy of bladder cancer: Bladder volume variation and its relation to margins. Radiotherapy and Oncology 84:3, pages 307-313.
Crossref
Crossref
Anne Birgitte Als, Lisa Sengelov & Hans von der Maase. (2007) Long-Term Survival after Gemcitabine and Cisplatin in Patients with Locally Advanced Transitional Cell Carcinoma of the Bladder: Focus on Supplementary Treatment Strategies. European Urology 52:2, pages 478-487.
Crossref
Crossref
William Chishing Cho. (2007) Progress of treatment for bladder cancer. Journal of Chinese Integrative Medicine, pages 85-91.
Crossref
Crossref
Anthony Thomas Redpath & Ludvig Paul Muren. (2006) CT-guided intensity-modulated radiotherapy for bladder cancer: Isocentre shifts, margins and their impact on target dose. Radiotherapy and Oncology 81:3, pages 276-283.
Crossref
Crossref
Lars Henningsohn. (2006) Quality of life after therapy for muscle-invasive bladder cancer. Current Opinion in Urology 16:5, pages 356-360.
Crossref
Crossref